Semaglutide 5mg | GLP-1 Receptor Agonist |

⚠️ ATTENTION: STRICTLY FOR LABORATORY RESEARCH USE ONLY. This product is NOT FOR HUMAN CONSUMPTION, medical use, veterinary use, or diagnostic use. By purchasing, you agree to handle this compound in compliance with all local and federal regulations.

The Apex of Neuro-Arousal & Central Signaling Research

PT-141 (Bremelanotide) represents the absolute pinnacle of laboratory research concerning sexual dysfunction, neuro-libido signaling, and central nervous system (CNS) arousal. In the landscape of molecular biology, PT-141 is a biological anomaly: it is a synthetic cyclic heptapeptide analog of the naturally occurring but with a structural refinement that focuses its activity almost exclusively on the neurological pathways of desire. Unlike traditional research subjects that target the peripheral vascular system—such as PDE5 inhibitors—PT-141 crosses the blood-brain barrier to activate the brain’s innate arousal centers directly.

Originally developed from the “tanning peptide” Melanotan II, PT-141 was engineered to isolate the aphrodisiac effects while stripping away the pigmentary (tanning) properties. This makes it a highly specific tool for researchers investigating the Hypothalamic-Pituitary-Gonadal (HPG) axis from a top-down, central perspective. By modulating the neural circuitry responsible for incentive motivation, PT-141 serves as the definitive gold standard for investigating Hypoactive Sexual Desire Disorder (HSDD) and the complex psychological-neurological intersections of intimacy.

The Architecture of CNS-Driven Desire

To understand the efficacy of the PT-141 10mg formulation in a research environment, one must examine its interaction with the Melanocortin System. The fundamental differentiator between PT-141 and other performance-based compounds is its site of action. While mechanical treatments rely on nitric oxide and local blood flow, PT-141 initiates a “desire signal” within the hypothalamus, the brain’s primary command center for survival and reproduction.

1. MC4R Activation: The Neurological Arousal Switch

PT-141 has a potent, non-selective binding affinity for melanocortin receptors, with its most significant research value lying in its activation of the Melanocortin 4 Receptor (MC4R). Activation of these receptors in the Medial Preoptic Area (MPOA) of the hypothalamus is the primary biological trigger for sexual arousal. Researchers utilize PT-141 to study how this central signal translates into a physical response, effectively “reconnecting” the brain to the body’s natural arousal mechanisms.

2. Dopaminergic Synergy and Incentive Motivation

Research indicates that MC4R activation leads to the downstream release of Dopamine in the Nucleus Accumbens and the Ventral Tegmental Area (VTA). This cross-talk between the melanocortin and dopaminergic systems is essential for studying “Incentive Motivation”—the drive to seek out rewarding stimuli. By enhancing this reward signaling, PT-141 allows for the investigation of libido restoration from a motivational, rather than purely mechanical, standpoint.

3. Hormonal Independence and Endocrine Resilience

A defining characteristic of PT-141 research is its efficacy regardless of baseline testosterone or estrogen levels. It does not alter the endocrine profile of the subject; rather, it optimizes how the brain interprets and responds to existing hormonal signals. This makes it a critical compound for studying sexual health in models where hormone replacement therapy is either contraindicated or insufficient.

Primary Domains of Laboratory Investigation

Detailed Breakdown of Research Applications

1. Hypoactive Sexual Desire Disorder (HSDD) Research

PT-141 is the gold standard for researching HSDD. In female research models, it is investigated for its ability to restore the neurological “appetite” for intimacy by dampening inhibitory signals and amplifying excitatory pathways in the brain. This makes it a critical subject for study in subjects where mechanical or hormonal solutions have failed to improve the subjective experience of desire.

2. Male Erectile Dysfunction (Non-Vascular Pathways)

In male models, PT-141 is used to study erectile function that originates in the brain. For subjects who do not respond to traditional blood-flow-enhancing compounds—often due to neurological, psychological, or diabetic factors—PT-141 offers a pathway to investigate the “central command” of the arousal response. It proves that physical readiness is often a secondary result of successful central signaling.

3. The Dopamine-Motivation Axis & Anhedonia

Beyond strictly sexual pathways, researchers utilize PT-141 to study general motivation and reward sensitivity. Because it interacts with the brain’s dopamine feedback loops, it is often modeled in research concerning lethargy, anhedonia (the inability to feel pleasure), and the restoration of proactive behavioral states in the face of metabolic or chronic stress.

Comparative Advantage: PT-141 vs. Melanotan II vs. PDE5 Inhibitors

In the landscape of bio-optimization and endocrine research, scientists must distinguish between Mechanical Performance and Neural Desire:

• PDE5 Inhibitors (Viagra/Cialis): Act on blood flow and nitric oxide. They fix the “mechanics” but do nothing for the “drive.”

• Melanotan II: Targets MC1R (skin) and MC4R (libido). While effective for arousal, it introduces the confounding variable of skin pigmentation (tanning).

• PT-141 (Bremelanotide): Specifically engineered to isolate the MC4R libido pathway while minimizing MC1R binding.

PT-141 allows researchers to isolate and study the effects on libido and CNS arousal without unwanted tanning side effects, making it the most precise and high-fidelity tool for neuro-libido studies currently available.

Laboratory Specifications & Compound Profile

This ultra-premium formulation is synthesized for rigorous laboratory environments demanding absolute molecular stability, unparalleled purity, and verified receptor affinity.

• Product Classification: Melanocortin Receptor Agonist (Heptapeptide).

• Molecular Weight: 1025.2 g/mol.

• Dosage / Yield: High-Purity 10mg (10,000mcg).

• Vial Size: 10ML standard clinical research format.

• Purity Standard: 99%+ (Independent Third-Party Lab Verified for structural integrity, correct cyclization, and receptor binding affinity).

• Storage Requirements: Store lyophilized powder at -20°C for long-term stability. Once reconstituted, refrigerate at 2°C to 8°C.